1. A. The secretary shall establish the "medical psilocybin advisory board", consisting of nine members who are knowledgeable about the medical use of psilocybin. At least one member shall be an enrolled member of an Indian nation, tribe or pueblo located wholly or partially in New Mexico; one member shall be licensed to provide behavioral health care services in New Mexico; one member shall be a mental or behavioral health equity advocate; one member shall be a representative of the health care authority; and at least one member shall be a veteran of the United States armed forces. A majority of the members constitutes a quorum, and a quorum of the members present and a majority vote are needed to take any action.

2. B. The board shall:

   1. (1) review and recommend to the department for approval medical conditions that may benefit from the medical use of psilocybin;
   2. (2) accept and review petitions to add medical conditions to the list of medical conditions that qualify for the medical use of psilocybin;
   3. (3) convene at least twice per year to conduct public hearings and to evaluate petitions, which shall be maintained as confidential personal health information;
   4. (4) recommend patient qualifications;
   5. (5) recommend formulation or preparation rules and dosage standards for psilocybin; and
   6. (6) assist the department in establishing, monitoring and evaluating best practices for producers and clinicians.

History: Laws 2025, ch. 73, § 8.

ANNOTATIONS

Effective dates. — Laws 2025, ch. 73 contained no effective date provision, but, pursuant to N.M. Const., art. IV, § 23, was effective June 20, 2025, 90 days after adjournment of the legislature.